Drug Profile
Research programme: efflux pump inhibitors - BioVie
Alternative Names: NA-MRSA; NA-TB; NEB-MRSA; NEB-TBLatest Information Update: 28 Jul 2018
Price :
$50
*
At a glance
- Originator Nano Antibiotics
- Developer BioVie
- Class
- Mechanism of Action Membrane protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Methicillin-resistant Staphylococcus aureus infections; Tuberculosis
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for research development in Methicillin-resistant-Staphylococcus-aureus-infections in USA
- 28 Jul 2018 No recent reports of development identified for research development in Tuberculosis in USA
- 27 Mar 2014 Early research in Methicillin-resistant Staphylococcus aureus infections in USA before March 2014 (unspecified route)